These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30864461)

  • 1. Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials.
    Cho M; Lee TY; Kwak YB; Yoon YB; Kim M; Kwon JS
    Aust N Z J Psychiatry; 2019 Aug; 53(8):742-759. PubMed ID: 30864461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial.
    Ritsner MS; Bawakny H; Kreinin A
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):432-40. PubMed ID: 24548129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.
    Sommer IE; de Witte L; Begemann M; Kahn RS
    J Clin Psychiatry; 2012 Apr; 73(4):414-9. PubMed ID: 22225599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis.
    Çakici N; van Beveren NJM; Judge-Hundal G; Koola MM; Sommer IEC
    Psychol Med; 2019 Oct; 49(14):2307-2319. PubMed ID: 31439071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Tabatabaee M; Amini H; Ahmadi Abhari SA; Abbasi SH; Behnam B
    Schizophr Res; 2007 Feb; 90(1-3):179-85. PubMed ID: 17208413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis.
    Kishi T; Ikuta T; Oya K; Matsunaga S; Matsuda Y; Iwata N
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):748-757. PubMed ID: 29762677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.
    Nitta M; Kishimoto T; Müller N; Weiser M; Davidson M; Kane JM; Correll CU
    Schizophr Bull; 2013 Nov; 39(6):1230-41. PubMed ID: 23720576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.
    Sommer IE; van Westrhenen R; Begemann MJ; de Witte LD; Leucht S; Kahn RS
    Schizophr Bull; 2014 Jan; 40(1):181-91. PubMed ID: 24106335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Oya K; Kishi T; Iwata N
    Hum Psychopharmacol; 2014 Sep; 29(5):483-91. PubMed ID: 25087702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kardashev A; Ratner Y; Ritsner MS
    Clin Schizophr Relat Psychoses; 2018; 12(1):31-41. PubMed ID: 26218236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
    Solmi M; Veronese N; Thapa N; Facchini S; Stubbs B; Fornaro M; Carvalho AF; Correll CU
    CNS Spectr; 2017 Oct; 22(5):415-426. PubMed ID: 28181901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled augmentation trials of the antioxidant NAC in schizophrenia: A review.
    Chen AT; Chibnall JT; Nasrallah HA
    Ann Clin Psychiatry; 2016 Aug; 28(3):190-6. PubMed ID: 27490835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
    Fond G; Mallet J; Urbach M; Benros ME; Berk M; Billeci M; Boyer L; Correll CU; Fornaro M; Kulkarni J; Leboyer M; Llorca PM; Misdrahi D; Rey R; Schürhoff F; Solmi M; Sommer IEC; Stahl SM; Pignon B; Berna F
    BMJ Ment Health; 2023 Oct; 26(1):. PubMed ID: 37852631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
    Xiang YQ; Zheng W; Wang SB; Yang XH; Cai DB; Ng CH; Ungvari GS; Kelly DL; Xu WY; Xiang YT
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):8-18. PubMed ID: 27919523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
    Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
    JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial.
    Chaudhry IB; Husain N; ur Rahman R; Husain MO; Hamirani MM; Kazmi A; Baig S; Haddad PM; Buch MH; Qureshi I; Mehmood N; Kiran T; Fu B; Afsar S; Deakin B
    Trials; 2015 Jan; 16():9. PubMed ID: 25563714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
    Chen X; Hong Y; Zheng P
    Psychiatry Res; 2015 Jul; 228(1):121-7. PubMed ID: 25980333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.